A late-stage trial failure involving a partner of AstraZeneca was announced, while the FDA concurrently approved Tryngolza for severe hypertriglyceridemia.
3 reports, 2 independent
Updated Aug 14
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A late-stage trial failure involving a partner of AstraZeneca was announced, while the FDA concurrently approved Tryngolza for severe hypertriglyceridemia.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Ionis Pharmaceuticals
American pharmaceutical company
Nothing else this week.
-
AstraZeneca
company in Osaka, Japan
Nothing else this week.
-
Food and Drug Administration
government organization in Nonthaburi, Thailand